Global Transdermal Drug Patches Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report ID: GIR2112290535 | Category: Pharma & Healthcare | Pages: 113 | Format: PDF | Published Date: November 17,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Transdermal Drug Patches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Transdermal Drug Patches market size is estimated to be worth US$ 6850.7 million in 2021 and is forecast to a readjusted size of USD 8516.5 million by 2028 with a CAGR of 3.2% during review period. Rx Channel accounting for % of the Transdermal Drug Patches global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Methyl Salicylate-based Patch segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Transdermal Drug Patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, and Mylan, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Transdermal Drug Patches market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Methyl Salicylate-based Patch
    Rivastigmine Transdermal Patch
    Fentanyl Transdermal Patch
    Lidocaine Patch
    Diclofenac Patch
    Nicotine Transdermal Patch
    Others
Market segment by Application can be divided into
    Rx Channel
    OTC Channel
The key market players for global Transdermal Drug Patches market are listed below:
    Hisamitsu Pharmaceutical
    Johnson & Johnson
    Novartis
    UCB Pharma
    Mylan
    Teva Pharmaceutical
    Nitto Denko
    Grünenthal
    IBSA Group
    GSK
    Luye Pharma Group
    Pfizer
    Chattem
    Dr Reddy’s Laboratories
    Bayer
    Mundipharma
    Endo International
    Beijing Tide Pharmaceutical
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transdermal Drug Patches product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Transdermal Drug Patches, with price, sales, revenue and global market share of Transdermal Drug Patches from 2019 to 2022.
Chapter 3, the Transdermal Drug Patches competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transdermal Drug Patches breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Transdermal Drug Patches market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Transdermal Drug Patches.
Chapter 13, 14, and 15, to describe Transdermal Drug Patches sales channel, distributors, customers, research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Transdermal Drug Patches Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Transdermal Drug Patches Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Methyl Salicylate-based Patch
        1.2.3 Rivastigmine Transdermal Patch
        1.2.4 Fentanyl Transdermal Patch
        1.2.5 Lidocaine Patch
        1.2.6 Diclofenac Patch
        1.2.7 Nicotine Transdermal Patch
        1.2.8 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Transdermal Drug Patches Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Rx Channel
        1.3.3 OTC Channel
    1.4 Global Transdermal Drug Patches Market Size & Forecast
        1.4.1 Global Transdermal Drug Patches Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Transdermal Drug Patches Sales in Volume (2017-2028)
        1.4.3 Global Transdermal Drug Patches Price (2017-2028) 
    1.5 Global Transdermal Drug Patches Production Capacity Analysis
        1.5.1 Global Transdermal Drug Patches Total Production Capacity (2017-2028)
        1.5.2 Global Transdermal Drug Patches Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Transdermal Drug Patches Market Drivers
        1.6.2 Transdermal Drug Patches Market Restraints
        1.6.3 Transdermal Drug Patches Trends Analysis
2 Manufacturers Profiles
    2.1 Hisamitsu Pharmaceutical
        2.1.1 Hisamitsu Pharmaceutical Details
        2.1.2 Hisamitsu Pharmaceutical Major Business
        2.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Product and Services
        2.1.4 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Johnson & Johnson
        2.2.1 Johnson & Johnson Details
        2.2.2 Johnson & Johnson Major Business
        2.2.3 Johnson & Johnson Transdermal Drug Patches Product and Services
        2.2.4 Johnson & Johnson Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Novartis
        2.3.1 Novartis Details
        2.3.2 Novartis Major Business
        2.3.3 Novartis Transdermal Drug Patches Product and Services
        2.3.4 Novartis Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 UCB Pharma
        2.4.1 UCB Pharma Details
        2.4.2 UCB Pharma Major Business
        2.4.3 UCB Pharma Transdermal Drug Patches Product and Services
        2.4.4 UCB Pharma Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Mylan
        2.5.1 Mylan Details
        2.5.2 Mylan Major Business
        2.5.3 Mylan Transdermal Drug Patches Product and Services
        2.5.4 Mylan Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Teva Pharmaceutical
        2.6.1 Teva Pharmaceutical Details
        2.6.2 Teva Pharmaceutical Major Business
        2.6.3 Teva Pharmaceutical Transdermal Drug Patches Product and Services
        2.6.4 Teva Pharmaceutical Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Nitto Denko
        2.7.1 Nitto Denko Details
        2.7.2 Nitto Denko Major Business
        2.7.3 Nitto Denko Transdermal Drug Patches Product and Services
        2.7.4 Nitto Denko Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Grünenthal
        2.8.1 Grünenthal Details
        2.8.2 Grünenthal Major Business
        2.8.3 Grünenthal Transdermal Drug Patches Product and Services
        2.8.4 Grünenthal Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 IBSA Group
        2.9.1 IBSA Group Details
        2.9.2 IBSA Group Major Business
        2.9.3 IBSA Group Transdermal Drug Patches Product and Services
        2.9.4 IBSA Group Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 GSK
        2.10.1 GSK Details
        2.10.2 GSK Major Business
        2.10.3 GSK Transdermal Drug Patches Product and Services
        2.10.4 GSK Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Luye Pharma Group
        2.11.1 Luye Pharma Group Details
        2.11.2 Luye Pharma Group Major Business
        2.11.3 Luye Pharma Group Transdermal Drug Patches Product and Services
        2.11.4 Luye Pharma Group Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 Pfizer
        2.12.1 Pfizer Details
        2.12.2 Pfizer Major Business
        2.12.3 Pfizer Transdermal Drug Patches Product and Services
        2.12.4 Pfizer Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.13 Chattem
        2.13.1 Chattem Details
        2.13.2 Chattem Major Business
        2.13.3 Chattem Transdermal Drug Patches Product and Services
        2.13.4 Chattem Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.14 Dr Reddy’s Laboratories
        2.14.1 Dr Reddy’s Laboratories Details
        2.14.2 Dr Reddy’s Laboratories Major Business
        2.14.3 Dr Reddy’s Laboratories Transdermal Drug Patches Product and Services
        2.14.4 Dr Reddy’s Laboratories Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.15 Bayer
        2.15.1 Bayer Details
        2.15.2 Bayer Major Business
        2.15.3 Bayer Transdermal Drug Patches Product and Services
        2.15.4 Bayer Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.16 Mundipharma
        2.16.1 Mundipharma Details
        2.16.2 Mundipharma Major Business
        2.16.3 Mundipharma Transdermal Drug Patches Product and Services
        2.16.4 Mundipharma Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.17 Endo International
        2.17.1 Endo International Details
        2.17.2 Endo International Major Business
        2.17.3 Endo International Transdermal Drug Patches Product and Services
        2.17.4 Endo International Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.18 Beijing Tide Pharmaceutical
        2.18.1 Beijing Tide Pharmaceutical Details
        2.18.2 Beijing Tide Pharmaceutical Major Business
        2.18.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Product and Services
        2.18.4 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Transdermal Drug Patches Breakdown Data by Manufacturer
    3.1 Global Transdermal Drug Patches Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Transdermal Drug Patches Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Transdermal Drug Patches
    3.4 Market Concentration Rate
        3.4.1 Top 3 Transdermal Drug Patches Manufacturer Market Share in 2021
        3.4.2 Top 6 Transdermal Drug Patches Manufacturer Market Share in 2021
    3.5 Global Transdermal Drug Patches Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Transdermal Drug Patches Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Transdermal Drug Patches Market Size by Region
        4.1.1 Global Transdermal Drug Patches Sales in Volume by Region (2017-2028)
        4.1.2 Global Transdermal Drug Patches Revenue by Region (2017-2028)
    4.2 North America Transdermal Drug Patches Revenue (2017-2028)
    4.3 Europe Transdermal Drug Patches Revenue (2017-2028)
    4.4 Asia-Pacific Transdermal Drug Patches Revenue (2017-2028)
    4.5 South America Transdermal Drug Patches Revenue (2017-2028)
    4.6 Middle East and Africa Transdermal Drug Patches Revenue (2017-2028)
5 Market Segment by Type
    5.1 Global Transdermal Drug Patches Sales in Volume by Type (2017-2028)
    5.2 Global Transdermal Drug Patches Revenue by Type (2017-2028)
    5.3 Global Transdermal Drug Patches Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global Transdermal Drug Patches Sales in Volume by Application (2017-2028)
    6.2 Global Transdermal Drug Patches Revenue by Application (2017-2028)
    6.3 Global Transdermal Drug Patches Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
    7.1 North America Transdermal Drug Patches Sales by Type (2017-2028)
    7.2 North America Transdermal Drug Patches Sales by Application (2017-2028)
    7.3 North America Transdermal Drug Patches Market Size by Country
        7.3.1 North America Transdermal Drug Patches Sales in Volume by Country (2017-2028)
        7.3.2 North America Transdermal Drug Patches Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
    8.1 Europe Transdermal Drug Patches Sales by Type (2017-2028)
    8.2 Europe Transdermal Drug Patches Sales by Application (2017-2028)
    8.3 Europe Transdermal Drug Patches Market Size by Country
        8.3.1 Europe Transdermal Drug Patches Sales in Volume by Country (2017-2028)
        8.3.2 Europe Transdermal Drug Patches Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Transdermal Drug Patches Sales by Type (2017-2028)
    9.2 Asia-Pacific Transdermal Drug Patches Sales by Application (2017-2028)
    9.3 Asia-Pacific Transdermal Drug Patches Market Size by Region
        9.3.1 Asia-Pacific Transdermal Drug Patches Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Transdermal Drug Patches Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
    10.1 South America Transdermal Drug Patches Sales by Type (2017-2028)
    10.2 South America Transdermal Drug Patches Sales by Application (2017-2028)
    10.3 South America Transdermal Drug Patches Market Size by Country
        10.3.1 South America Transdermal Drug Patches Sales in Volume by Country (2017-2028)
        10.3.2 South America Transdermal Drug Patches Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Transdermal Drug Patches Sales by Type (2017-2028)
    11.2 Middle East & Africa Transdermal Drug Patches Sales by Application (2017-2028)
    11.3 Middle East & Africa Transdermal Drug Patches Market Size by Country
        11.3.1 Middle East & Africa Transdermal Drug Patches Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Transdermal Drug Patches Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
    12.1 Raw Material of Transdermal Drug Patches and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Transdermal Drug Patches
    12.3 Transdermal Drug Patches Production Process
    12.4 Transdermal Drug Patches Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Transdermal Drug Patches Typical Distributors
    13.3 Transdermal Drug Patches Typical Customers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Transdermal Drug Patches Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?